Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Genomic Health gets exclusive rights to sell Epic's liquid biopsy test in the US

Executive Summary

Epic Sciences Inc. granted Genomic Health Inc. exclusive rights to sell its ARV7 liquid biopsy test in the US to assist in treatment planning in patients with metastatic castration-resistant prostate cancer (mCRPC).
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Includes Royalty or Profit Split Information
    • Intra-Biotech Deal
    • Marketing-Licensing

Related Companies

Advertisement
UsernamePublicRestriction

Register